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Exogenous high-mobility group box 1 protein (HMGB1) injection could prevent left ventricular remodeling and enhance left
ventricular function during myocardial infarction (MI). However, the mechanism remains unclear. This paper was to investigate
in the mechanism of cardioprotection of HMGB1 during MI in rats. Anesthetized male rats were treated once with HMGB1
(200ng) 4h after MI and then executed after 7 and 28 days, respectively. Cardiac function, collagen deposition, and dishevelled-
1a n dβ-catenin protein expression were measured. After MI 7 days or 28 days, the left ventricular ejection fraction (LVEF)
was signiﬁcantly decreased compared to that of sham-operated control group (P<0.05). However, the LVEF HMGB1-treated
groups were signiﬁcantly higher compared to those of the MI group in both 7 days and 28 days (P<0.05). The collagen volume
fraction was signiﬁcantly reduced in the HMGB1-treated group in infarcted border zone. HMGB1 could activate the expression of
dishevelled-1 and β-catenin proteins (P<0.05). Our study suggested that exogenous high-mobility group box 1 protein injection
improves cardiac function after MI, which may be involved in Wnt/β-catenin signaling activation.
1.Introduction
Myocardial infarction (MI) is one of the leading cause of
morbility and mortality [1]. The healing process after MI
involves early cardiomyocytes apoptosis and inﬂammatory
cells inﬁltration, which also includes the proliferation and
migration of myoﬁbroblasts with the degradation and
deposition of extracellular matrix. This pathological change
induces the damaged myocardium to be replaced with scar
tissue, which leads to “left ventricular remodeling” and heart
failure [2, 3]. High-mobility group box 1 protein (HMGB1),
a multifunctional protein, was originally identiﬁed as a
nuclear protein and secreted from inﬂammatory cells to
modulate inﬂammation and function as a mediator of
inﬂammation in several cardiovascular diseases, such as
coronary artery disease, myocardial ischemia, and reperfu-
sion injury and heart failure [4–7]. Present studies revealed
variable eﬀects of HMGB1 to inﬂammation; it acts as a
“double-edged sword,” not only initiating/amplifying but
also attenuating the response [8, 9]. Recent studies have
conﬁrmed a novel role for HMGB1 as a strong chemoattrac-
tant and a signal of tissue damage to promote proliferation,
migration, and diﬀerentiation of several stem cell types and
could prevent left ventricular remolding and enhance left
ventricular function during MI [10–12]. However, the above
mechanism remains unclear.
Wnt proteins are a large family of secreted signaling
molecules. Present study showed that the Wnt pathway is
involved in post-MI wound healing and stem cell regulation,
which has been shown to play an essential role in cell
proliferation and diﬀerentiation both in normal homeosta-
sis and diseased state [13–17]. On base of the common
beneﬁcial eﬀects of HMGB1 and Wnt signal pathway in
cardiac function healing after MI, we speculated that there
exists a potential relationship between HMGB1 and Wnt
signal pathway. In this present study, we investigated that
whether exogenous HMGB1 injection could improve the
cardiac function by mediating Wnt signal pathway.2 Journal of Biomedicine and Biotechnology
2.MaterialsandMethods
2.1. Animal Experiments and Protein Injection. The experi-
ment protocol conformed to the Guideline for the Care and
Use of Laboratory Animals published by the US National
Institutes of Health (NIH Publication, revised 1996) and was
approved by Institutional Animal Care and Use Committee.
Male Sprague-Dawley rats with an initial weight from 200
to 250g were randomly assigned into 5 groups receiving the
following treatments.
Group1:sham-operatedcontrol(SO)(n = 10):ratswere
subjected to surgical manipulation without MI.
Group 2: MI/7 days (n = 1 5 ) :r a t sw e r es u b j e c t e dt ol e f t
anterior descending coronary artery occlusion, after 4 hours
they were treated with Phosphate-Buﬀered Saline (PBS) and
were executed after 7 days.
Group 3: MI/28 days (n = 1 5 ) :r a t sw e r es u b j e c t e dt o
left anterior descending coronary artery occlusion and were
executed after 28 days.
Group 4: MI-HMGB1/7 days (n = 15): rats were sub-
jected to left anterior descending coronary artery occlusion,
after 4 hours they were treated with HMGB1 (200ng) and
were executed after 7 days.
Group 5: MI-HMGB1/28 days (n = 1 5 ) :r a t sw e r es u b -
jected to left anterior descending coronary artery occlusion,
after 4 hours they were treated with HMGB1 (200ng) and
were executed after 28 days.
After being anesthetized with sodium pentobarbital
(40mg/kg, i.p.), the rats were ventilated artiﬁcially with
a volume-controlled rodent respirator at 70 strokes per
minute. Rats were placed on an electric heating pad to main-
tain the body temperature at 37◦C. Animals were treated
with heparin (200IU/kg, iv) and then a left thoracotomy
was performed. The left coronary artery was identiﬁed and
ligated 2mm below the left atrial appendage. A successful MI
model was conﬁrmed by ST segment elevation in Leads-II
and regional cyanosis of the myocardial surface. The chest
was closed and the rats were allowed to recover. After 4
hours,ratswereunderrethoracotomy,and200ngofpuriﬁed
HMGB1 in 10uL PBS solution was injected into 2 sites of
the peri-infarct zone. The dose of HMGB1 was determined
basedonthepreviousliteraturebyLimanaetal.[12].Lead-II
of the electrocardiogram was monitored with subcutaneous
stainless steel electrodes. Electrocardiogram was monitored
using a computer-based EP system (LEAD2000B, Jinjiang
Ltd, China). To determine serial HMGB1 expression, rats
were sacriﬁced 7 and 28 days after MI for mRNA and protein
analyses.
2.2. Assessment of Cardiac Function. Echocardiography was
performed to evaluate cardiac function in anesthesia rats
using Sequoia 512 (Acuson, Mountain View, CA, USA)
equipped with a 3–7MHz linear transducer at 7 and 28 days
afterHMGB1orPBSinjection.Two-dimensionalimagesand
M - m od etrac i n gsw e r er ec o r d edf r o mt h ea n t e ri o rc h e s ta r e a .
2.3. Tissue Repair. Rats in each group were killed at 7 and
28 days after MI, respectively; and the left ventricular tissue
specimens were immediately put into liquid nitrogen for 24
hours and then reserved in −80◦Cr e f r i g e r a t o r .
2.4. Western Blot. Pulverized frozen ischemia area of the
left ventricle samples were analyzed by quantitative imm-
unoblotting using dishevelled-1 and β-catenin antibody
(Santa Cruz, USA) as described previously [5]. The exp-
ression of protein was normalized to glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) expression.
2.5. RNA Isolation, cDNA Synthesis, and Real-Time
PCR. Total RNA was isolated from myocardial tissue
by TRIZOL (Invitrogen) extraction and cDNA generated
using High Capacity cDNA Reverse Transcription kit
(TaKaRa, Japan). For real-time PCR analysis, we performed
on ABI Prism 7500 sequence detection system (PE
Applied Biosystems) by using SYBR Green Real-time PCR
Master Mix kit (TaKaRa, Japan). PCR cycling conditions
included 42◦C/30min, 99◦C/10min,5◦C/5min for reverse
transcription; 94◦C/30s, 51◦C( D V L ) ,o r5 5 ◦C(β-actin)/30s
and 72◦C/60s, over 35 cycles for polymerase chain reaction.
Semilog ampliﬁcation curves were evaluated based on
2−ΔΔCt (comparative quantiﬁcation method). β-actin
was selected as normalization for each sample and the
reaction conditions exactly the same as specimens. The
primers used were as follows: dishevelled-1, forward
primer: 5 TCACGCTCAACATGGAGAGGCA3 ;r e v e r s e
primer: 5 GCACGGCATCATCGTTGCTCAT3 . (Gene Bank
number: 83721). β-actin, forward primer: 5 ACTGGCATTG
TGATGGACTCCGGA3  reverse primer: 5 TCTCAGCTGTG
GTGGTGAAGCTGT3 . (Gene Bank number: 81822)
2.6. Histology. Excised hearts were immersion-ﬁxed in 10%
buﬀered formalin for 24 hours and transferred to 70%
ethanol to obtain serial sections at set time points. The
specimens were sliced from apex to base into 4mm thick
sections and mounted on a set of gelatin-coated glass slides.
These slides were stained with Masson trichrome. Five slides
equally distributed through the infarct area were taken from
a representative heart sample and scar thickness.
2.7. Statistical Analysis. Statistical analysis was performed
with the SPSS 13.0 (SPSS Inc., Chicago, IL, USA). All values
were expressed as mean ± SD. One-way ANOVA or Welch
was used for comparisons among groups, and the Newman-
Keuls-Student or Dunnett T3 was used for post hoc multiple
comparisons. Statistical signiﬁcance was deﬁned as P<0.05.
3. Results
3.1. Cardiac Function. As shown in Table 1, after MI of 7
days or 28 days, the left ventricular ejection fraction (LVEF)
were signiﬁcantly decreased compared to that of SO group
(P<0.05). However, the LVEF treated with HMGB1 were
signiﬁcantly higher compared to those of the MI group both
in 7 days and 28 days (P<0.05). Left Ventricular End-
Systolic Volume (LVESV) and Left Ventricular End-Diastolic
Volume (LVEDV) seemed to be larger in the SO groupJournal of Biomedicine and Biotechnology 3
Table 1: Cardiac function in SO, MI, and MI-HMGB1 group at 7 and 28 days.
7 days 28 days
SO MI MI-HMGB1 MI MI-HMGB1
HR (bpm) 334 ±13 324 ±11 344 ±12 338 ±13 351 ±14
LVEF (%) 70.2 ±3.24 3 .1 ±8.3∗ 53.42 ±7.3∗# 30.33 ±4.6∗ 50.61 ±7.6∗#
LVEDV (cm2)0 .41 ±0.02 0.61 ±0.03∗ 0.64 ±0.04∗ 0.70 ±0.04∗ 0.68 ±0.03∗
LVSA (cm2)0 .23 ±0.03 0.41 ±0.04∗ 0.49 ±0.05∗ 0.53 ±0.02∗ 0.50 ±0.04∗
SO, sham-operated control; MI, myocardial infarction; HR, heart rate; HMGB1, high-mobility group box 1 protein; LVEF, left ventricular ejection fraction;
LVEDV, Left ventricular end-diastolic volume; LVESV, Left ventricular end-systolic volume ∗P<0.05 versus SO group; #P<0.05 versus MI group.
compared to HMGB1-treated group (P<0.05). However,
no signiﬁcant change can be observed in heart rate of MI-
HMGB1 group and MI group in 7 days and 28 days.
3.2. Wnt/β-Catenin Expression. As shown in Figure 1,
the expression of dishevelled-1 protein was signiﬁcantly
increased in both MI/7 days and MI-HMGB1/7 days (groups
2 and 4) compared to that of SO group (P<0.05). However,
dishevelled-1 protein has a sudden drop and could hardly
be detected in MI/28 days (group 3). Conversely, it was
signiﬁcantly increased in MI-HMGB1/28 days (group 5)
(P<0.05).
Subsequently, to further clarify the change mechanism,
weconductedastudyonβ-catenin.β-cateninhashistorically
to be recognized as a second messenger and located down-
stream of dishevelled-1 in canonical Wnt pathway [14]. Data
analysis from our experiment suggested that the trend of its
protein expression, consistent with dishevelled-1, increased
signiﬁcantly at MI/7 days (group 2) and then turn to almost
undetectable levels in MI/28 days (group 3), while it was
continually increasing from 7 to 28 days in MI-HMGB1/7
days and MI-HMGB1/28 days (groups 4 and 5) (P<0.05).
3.3. Dishevelled-1 mRNA Expression. We investigated nor-
malizedDishevelled-1mRNAlevelfromanalysisofreal-time
PCR results. As shown in Figure 2, compared with sham-
operated group, expression of dishevelled-1 mRNA increases
both in MI/7 days and MI-HMGB1/7 days (group2 and
4) (P<0.05), and then the dishevelled-1 gene expression
decreased abruptly in MI/28 days (group 3) (P<0.05).
While the dishevelled-1 mRNA expression has a markedly
increasing in MI-HMGB1/28 days group (group 5) (P<
0.05).
3.4. Collagen Deposition. As shown in Figure 3,f r o m7d a y s
to 28 days after MI, ventricular wall of the infarcted area
became grey and stiﬀ in all groups, and Masson trichrome
staining detected a huge amount of collagen deposition in
the peri-infarct area of MI/7 days and 28 days, while it was
signiﬁcantly reduced in the MI-HMGB1/7 days and 28 days
(P<0.05). Quantitative analysis also demonstrates that the
collagen volume fraction was signiﬁcantly reduced in the
HMGB1-treated group in infarcted border zone.
4. Discussion
In this study, we found that exogenous HMGB1 injection
could improve cardiac function and activate the Wnt signal-
ing pathway after MI. Thus, we speculated that HMGB1’s
beneﬁcial eﬀect in cardiac function during heart healing
may be associated with the activation of the Wnt signaling
pathway.
To be considered as a double-edged sword, HMGB1
massivelyreleasedbynecroticcell,apoptoticcell,oractivated
innate immune cells (such as macrophages and monocytes)
have both beneﬁcial and detrimental eﬀects [4, 8]. A series
of recent articles have demonstrated that HMGB1 could
improve global cardiac function of chronic heart failure and
promote myocardial regeneration after MI [7, 12, 18]. In
the present study, we also showed that exogenous HMGB1
injection into the rat heart at the time of MI could induce an
enhancement of cardiac function and attenuate pathological
extracellular matrix accumulation.
It is well known that the pathologic process of wound
healing after MI includes cell proliferation and migration,
extracellular matrix degradation and deposition, scar tissue
formation and maturation. Previous study has conﬁrmed
that exogenous HMGB1 could induce myocardial regener-
ation after infarction via enhanced cardiac C-Kit cell prolif-
eration and diﬀerentiation; at the same time, they observed
newly formed cardiomyocytes present in the infarcted area,
which express cardiac markers like myocyte enhancer factor-
2C, α-sarcomeric actin, and connexin43 (Wnt signaling is
also a speciﬁc and potent inducer of connexin43 expression
incardiomyocytes[9,19].Sinceseveralgroupshaveexplored
that the migration and proliferation of cardiac stem cells
were governed by diﬀerent molecular signaling cascades
during infarct healing, in which of them Wnt signaling plays
a functional role. Mirotsou et al. [20] further demonstrated
thatWntplaysamajorroleinmediatingthesurvivalsignalof
Akt-overexpressing mesenchymal stem cell on the ischemic
myocardium. In the present study, the Wnt/β-catenin signal
pathway was activated by exogenous HMGB1 injection after
MI. Therefore, we speculated that the beneﬁcial eﬀects of
HMGB1-inducing cell diﬀerentiation were possible depend-
ing on activation of Wnt/β-catenin signaling in damaged
heart tissue after MI, and ﬁnally resulting in improvement
of cardiac function.
Dishevelled-1 is a core molecule, which mediate the Wnt
signal’s delivery from receptor to intracellular, three highly4 Journal of Biomedicine and Biotechnology
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Figure 1: Expression of dishevelled-1 and β-catenin protein at
diﬀerent time points after MI without/with HMGB1 injection (n =
5 for each group). #P<0.05 versus SO group; P<0.05 versus
MI/7 days; P<0.05 versus MI/28 days. SO, sham-operated
control; MI, myocardial infarction; HMGB1, high-mobility group
box 1 protein.
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Figure 2: Expressions of dishevelled-1 mRNA at diﬀerent time
points in diﬀerent experimental groups (n = 5 for each group).
#P<0.05 versus SO group; P<0.05 versus MI/7 days; P<0.05
versus MI/28 days. Abbreviations are identical with Figure 1.
conserved domain of it are necessary for activation of Wnt
[21]. In this study, our data showed that the dishevelled-
1 mRNA and protein increased in 7 days after MI, which
may be attributed to the protection of compensation, but
decreased signiﬁcantly in MI rats in 28 days. This may
be an essential mechanism for left ventricular remodeling
consistent with previous study [22]. However, the expression
ofdishevelled-1mRNAwashardlydecreasedinMIratswhile
sharply increased in response to exogenous HMGB1 injec-
tion in 28 days. Meanwhile, we also found that exogenous
HMGB1 injection could inhibit the decrease of β-catenin
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Figure 3: Representative Masson trichrome-stained sections (blue)
of hearts after MI (n = 5 for each group). P<0.05 versus MI/7
days; P<0.05 versus MI/28 days. Abbreviations are identical with
Figure 1.
induced by MI. Existing studies aiming at wound healing
after MI reported an upregulation of β-catenin in vascu-
lar endothelial cells during neovascularization and could
contribute to myoﬁbroblast’s migration and proliferation,
promote granulation tissue formation and maturation, help
to repair the damaged myocardium; these suggested that the
changeofβ-cateninplaysanimportantroleinleftventricular
remodeling after MI [23]. In addition, previous studies
indicated that dishevelled-1 could upregulate and activate β-
catenin during the wound-healing process after MI [22, 24,
25]. Thus, we speculated that exogenous HMGB1 injection
could improve cardiac function by mediating Wnt/β-catenin
signaling pathway after MI.
5. Conclusions
Our study suggested that HMGB1 could mediate Wnt
signaling through upregulating the level of dishevelled-1,
then upregulating β-catenin after MI, and ﬁnally result in
improving cardiac function, which may become a potential
therapeutic target for post-MI heart failure.
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